SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-337294
Filing Date
2021-11-23
Accepted
2021-11-23 06:27:02
Documents
14
Period of Report
2021-11-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d231595d8k.htm   iXBRL 8-K 23333
2 EX-99.1 d231595dex991.htm EX-99.1 34973
6 GRAPHIC g231595g46j74.jpg GRAPHIC 14998
  Complete submission text file 0001193125-21-337294.txt   217032

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aadi-20211123.xsd EX-101.SCH 2880
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20211123_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20211123_pre.xml EX-101.PRE 11852
7 EXTRACTED XBRL INSTANCE DOCUMENT d231595d8k_htm.xml XML 3486
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 211434644
SIC: 2834 Pharmaceutical Preparations